VEGFA and neoplasm: So far, there have been no studies exploring which of the above-mentioned mechanisms is dominant for EV-associated integrins and whether the predominance of either αvβ3 integrin/TNF-α or αvβ5 integrin/VEGF pathway changes with tumor progression.